Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides
- 2 June 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (11) , 2870-2875
- https://doi.org/10.1016/j.bmcl.2005.03.090
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agentsBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 2: Improvement of in vitro activityBioorganic & Medicinal Chemistry Letters, 2004
- A novel series of potent and selective IKK2 inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Novel IKK inhibitors: β-carbolinesBioorganic & Medicinal Chemistry Letters, 2003
- Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1Bioorganic & Medicinal Chemistry Letters, 2003
- Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint diseaseCurrent Opinion in Pharmacology, 2002
- The IKK/NF-κB pathwayCritical Care Medicine, 2002
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001
- NF-κB to the rescue: RELs, apoptosis and cellular transformationTrends in Genetics, 1999
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996